drugset / Trial / NCT01847391
A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects
RandomizedFactorialSingle-blindTreatment
Summary
This is a phase 1, single-blind, randomized, placebo-controlled, multiple ascending dose study aimed to assess the safety, tolerability, and pharmacokinetics of GS-6615 in healthy subjects.
Timeline
- Start
- 2013-05
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eleclazine | Small molecule | 3 mg | Oral |
| Subject | Eleclazine | Small molecule | 6 mg | Oral |
| Subject | Eleclazine | Small molecule | 9 mg | Oral |